Performance of a Quadruple Combination Including Nelfinavir Plus Efavirenz in Naive Subjects With High Baseline Viral Load and in Patients Failing Protease Inhibitor-Containing Regimens
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 26 (4) , 391-392
- https://doi.org/10.1097/00042560-200104010-00020
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Induction-Maintenance (5 → 3 Drugs) in HIV-Infected Patients with High Viral LoadAIDS Patient Care and STDs, 2000
- Potent Activity but Limited Tolerance of Ritonavir Plus Indinavir in Salvage InterventionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAJournal of Clinical Investigation, 2000
- Efavirenz, Nelfinavir, and Stavudine Rescue Combination Therapy in HIV-1–Positive Patients Heavily Pretreated With Nucleoside Analogues and Protease InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- What dual protease inhibitor combination for salvage therapies?AIDS, 1999
- Introduction of HIV drug-resistance testing in clinical practiceAIDS, 1999
- Novel Four‐Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor–Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic OutcomeThe Journal of Infectious Diseases, 1999
- Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavirAIDS, 1999